annual working capital:
$946.24M+$312.31M(+49.27%)Summary
- As of today (June 22, 2025), HALO annual working capital is $946.24 million, with the most recent change of +$312.31 million (+49.27%) on December 31, 2024.
- During the last 3 years, HALO annual working capital has risen by +$137.10 million (+16.94%).
- HALO annual working capital is now at all-time high.
Performance
HALO Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$1.11B+$165.41M(+17.48%)Summary
- As of today (June 22, 2025), HALO quarterly working capital is $1.11 billion, with the most recent change of +$165.41 million (+17.48%) on March 31, 2025.
- Over the past year, HALO quarterly working capital has increased by +$369.70 million (+49.83%).
- HALO quarterly working capital is now at all-time high.
Performance
HALO quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
HALO Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.3% | +49.8% |
| 3 y3 years | +16.9% | +26.8% |
| 5 y5 years | +106.7% | +161.0% |
HALO Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.6% | at high | +224.6% |
| 5 y | 5-year | at high | +609.4% | at high | +733.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
HALO Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.11B(+17.5%) |
| Dec 2024 | $946.24M(+49.3%) | $946.24M(-7.1%) |
| Sep 2024 | - | $1.02B(+19.2%) |
| Jun 2024 | - | $854.44M(+15.2%) |
| Mar 2024 | - | $741.95M(+17.0%) |
| Dec 2023 | $633.93M(+4.2%) | $633.93M(-17.0%) |
| Sep 2023 | - | $763.82M(+17.6%) |
| Jun 2023 | - | $649.35M(+24.1%) |
| Mar 2023 | - | $523.10M(-14.0%) |
| Dec 2022 | $608.22M(-24.8%) | $608.22M(+11.8%) |
| Sep 2022 | - | $543.82M(+58.8%) |
| Jun 2022 | - | $342.43M(-61.0%) |
| Mar 2022 | - | $877.00M(+8.4%) |
| Dec 2021 | $809.14M(+506.6%) | $809.14M(-10.5%) |
| Sep 2021 | - | $904.15M(+2.1%) |
| Jun 2021 | - | $885.50M(+6.1%) |
| Mar 2021 | - | $834.30M(+525.5%) |
| Dec 2020 | $133.38M(-70.9%) | $133.38M(-71.7%) |
| Sep 2020 | - | $471.92M(-0.5%) |
| Jun 2020 | - | $474.29M(+11.3%) |
| Mar 2020 | - | $425.97M(-7.0%) |
| Dec 2019 | $457.80M(+64.4%) | $457.80M(+95.6%) |
| Sep 2019 | - | $234.00M(-8.7%) |
| Jun 2019 | - | $256.29M(-5.2%) |
| Mar 2019 | - | $270.37M(-2.9%) |
| Dec 2018 | $278.49M(-26.5%) | $278.49M(-4.2%) |
| Sep 2018 | - | $290.81M(-11.8%) |
| Jun 2018 | - | $329.60M(-9.8%) |
| Mar 2018 | - | $365.25M(-3.6%) |
| Dec 2017 | $379.04M(+87.7%) | $379.04M(+50.8%) |
| Sep 2017 | - | $251.30M(-2.7%) |
| Jun 2017 | - | $258.22M(+60.7%) |
| Mar 2017 | - | $160.65M(-20.5%) |
| Dec 2016 | $201.95M(+84.7%) | $201.95M(-8.2%) |
| Sep 2016 | - | $219.94M(-10.4%) |
| Jun 2016 | - | $245.46M(+5.4%) |
| Mar 2016 | - | $232.81M(+113.0%) |
| Dec 2015 | $109.31M(-20.2%) | $109.31M(+1.0%) |
| Sep 2015 | - | $108.24M(-18.9%) |
| Jun 2015 | - | $133.40M(+4.9%) |
| Mar 2015 | - | $127.12M(-7.2%) |
| Dec 2014 | $136.99M(+94.9%) | $136.99M(+10.5%) |
| Sep 2014 | - | $124.01M(-13.8%) |
| Jun 2014 | - | $143.90M(-6.9%) |
| Mar 2014 | - | $154.55M(+119.9%) |
| Dec 2013 | $70.29M | $70.29M(+11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $63.19M(-6.5%) |
| Jun 2013 | - | $67.59M(-26.0%) |
| Mar 2013 | - | $91.36M(-18.2%) |
| Dec 2012 | $111.68M(+139.2%) | $111.68M(+32.0%) |
| Sep 2012 | - | $84.58M(-18.3%) |
| Jun 2012 | - | $103.58M(-10.6%) |
| Mar 2012 | - | $115.89M(+148.2%) |
| Dec 2011 | $46.69M(-37.0%) | $46.69M(-26.1%) |
| Sep 2011 | - | $63.18M(+11.9%) |
| Jun 2011 | - | $56.47M(-15.2%) |
| Mar 2011 | - | $66.59M(-10.2%) |
| Dec 2010 | $74.16M(+23.5%) | $74.16M(-14.4%) |
| Sep 2010 | - | $86.65M(+126.5%) |
| Jun 2010 | - | $38.26M(-21.8%) |
| Mar 2010 | - | $48.92M(-18.5%) |
| Dec 2009 | $60.04M(+0.4%) | $60.04M(-11.2%) |
| Sep 2009 | - | $67.59M(-13.9%) |
| Jun 2009 | - | $78.48M(+48.5%) |
| Mar 2009 | - | $52.85M(-11.6%) |
| Dec 2008 | $59.79M(-35.2%) | $59.79M(-11.0%) |
| Sep 2008 | - | $67.17M(-12.4%) |
| Jun 2008 | - | $76.71M(-11.8%) |
| Mar 2008 | - | $87.02M(-5.7%) |
| Dec 2007 | $92.31M(+123.3%) | $92.31M(-7.5%) |
| Sep 2007 | - | $99.81M(+3.0%) |
| Jun 2007 | - | $96.94M(+42.3%) |
| Mar 2007 | - | $68.14M(+64.8%) |
| Dec 2006 | $41.34M(+132.2%) | $41.34M(+183.7%) |
| Sep 2006 | - | $14.57M(+3.9%) |
| Jun 2006 | - | $14.03M(-11.7%) |
| Mar 2006 | - | $15.89M(-10.8%) |
| Dec 2005 | $17.80M(+22.2%) | $17.80M(+247.3%) |
| Sep 2005 | - | $5.13M(-42.0%) |
| Jun 2005 | - | $8.83M(-24.0%) |
| Mar 2005 | - | $11.61M(-20.3%) |
| Dec 2004 | $14.57M(>+9900.0%) | $14.57M(+799.5%) |
| Sep 2004 | - | $1.62M(-65.8%) |
| Jun 2004 | - | $4.73M(-30.3%) |
| Mar 2004 | - | $6.80M(>+9900.0%) |
| Sep 2003 | - | $60.90K(-10.2%) |
| Jun 2003 | - | $67.80K(-12.5%) |
| Mar 2003 | - | $77.50K(-27.7%) |
| Sep 2002 | - | $107.20K(-10.1%) |
| Jun 2002 | - | $119.20K(+263.4%) |
| Mar 2002 | - | $32.80K |
| Dec 2001 | $22.80K | - |
FAQ
- What is Halozyme Therapeutics annual working capital?
- What is the all time high annual working capital for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual working capital year-on-year change?
- What is Halozyme Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly working capital year-on-year change?
What is Halozyme Therapeutics annual working capital?
The current annual working capital of HALO is $946.24M
What is the all time high annual working capital for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual working capital is $946.24M
What is Halozyme Therapeutics annual working capital year-on-year change?
Over the past year, HALO annual working capital has changed by +$312.31M (+49.27%)
What is Halozyme Therapeutics quarterly working capital?
The current quarterly working capital of HALO is $1.11B
What is the all time high quarterly working capital for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly working capital is $1.11B
What is Halozyme Therapeutics quarterly working capital year-on-year change?
Over the past year, HALO quarterly working capital has changed by +$369.70M (+49.83%)